Ekterly becomes the first FDA-approved oral on-demand treatment for hereditary angioedema in patients aged 12 years and older ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Ekterly is the first and only oral on-demand therapy for treating attacks associated with hereditary angioedema – – DRI Healthcare is entitled to a ...

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Another Rock Island County Sheriff’s Office deputy said he intends to run for sheriff in 2026. Timothy Gillette, a 28-year ...

United States Attorney Timothy Courchaine announced criminal charges against seven defendants in connection with alleged ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

"No More Tears," by Gardiner Harris, is a scathing expose of Johnson & Johnson and its many missteps and transgressions.

Despite the many warnings by law enforcement — reinforced by this newspaper — to be wary of anyone purporting to act in your best interests, egregious examples of violations of that trust continue to ...

According to a press release from ECPD, Sims is accused of terrorizing and injuring an elderly woman during a” “drug-induced crime spree” the night of May 29, later stealing a knife and ...

The FDA is moving at breakneck speed to roll out a generative artificial intelligence (AI) tool for speeding up regulatory reviews, announcing its launch nearly a month ahead of the 30th June ...